Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study
Abstract Background Although biologic agents have revolutionized the medical management of severe ulcerative colitis (UC), there is considerable controversy regarding adverse effects of vedolizumab on surgical outcomes. We evaluated 30-day postoperative morbidity in UC patients undergoing abdominal...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-03-01
|
| coleção: | BMC Surgery |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12893-020-00698-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|